Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.

Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.
复制标题

DOI:
10.1371/journal.pone.0086853
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Xin W
Xin W
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Xiao W;Hong H;Awadallah A;Zhou L;Xin W

文献摘要

参考文献

被引文献

相似文献

CDX2, a master transcriptional regulator of intestinal cell differentiation and survival, has been used as a marker to indicate colorectal lineage in adenocarcinomas of unknown origin. Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes for adenocarcinomas of unknown origin, but CDX2 expression in pancreatic disease remains unclear. In this study, we systemically and extensively investigated the expression and role of CDX2 in PDAC. We reported that CDX2 expression is weak and heterogeneous is all normal pancreas and chronic pancreatitis. It is largely expressed in epithelial-lining cells of pancreatic ducts including main ducts, inter-lobular ducts, intra-lobular ducts, intercalated ducts and centroacinar cells, but not in acinar cells or islet cells. CDX2 expression is down regulated during the transformation process from PanIN to PDAC. Only one third of PDACs retain some degree of CDX2 expression, and this group of PDACs have reduced median survival time compared to that of CDX2 negative group (308 days vs. 586 days, p = 0.0065). Metastatic PDACs remain similar expression pattern to that of the primary sites. Our study clearly demonstrates CDX2 expression in pancreatic diseases including PDAC, which is practically important when CDX2 is used to establish the primary sites of adenocarcinomas of unknown origin. In addition, our study also provides CDX2 as a prognostic marker for PDAC and implicates an important role of CDX2 in the development of normal pancreas and PDAC.
DOI: 10.1007/s00432-003-0499-6
发表时间: 2003-12-01
影响因子: 3.6
作者:
Mizoshita, T;Tsukamoto, T;Tatematsu, M
通讯作者: Tatematsu, M
DOI: 10.5858/arpa.2011-0326-oa
发表时间: 2012-06-01
影响因子: 4.6
作者:
Liu, Haiyan;Shi, Jianhui;Lin, Fan
通讯作者: Lin, Fan
DOI: 10.1007/s12253-010-9346-7
发表时间: 2011-09
期刊: Pathology oncology research : POR
影响因子: --
作者:
Li QL;Yang ZL;Liu JQ;Miao XY
通讯作者: Miao XY
DOI: 10.1111/j.1440-1746.2006.04487.x
发表时间: 2007-03-01
影响因子: 4.1
作者:
Chang, Yu-Ting;Hsu, Chiun;Wong, Jau-Min
通讯作者: Wong, Jau-Min
DOI: 10.1097/igc.0b013e318261d89c
发表时间: 2012-09-01
影响因子: 4.8
作者:
Huang, Li-Ping;Yu, Yan-Hong;Wang, Sui-Hai
通讯作者: Wang, Sui-Hai